MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647126833 A) filed by Leadingtac Pharmaceutical Shaoxing Co. , Ltd. on October 24, 2026, for Kras Degradation Agent As Well As Preparation Method Therefor And Use Thereof.
Inventors include Ye, Zhengqing; Feng, Yan; Ding, Chenli; and Xu, Juan.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: Disclosed in the present invention are a KRAS G12D degradation agent as well as a preparation method therefor and the use thereof. The present invention provides compounds as shown below, and/or stereoisomers, enantiomers, diastereoisomers, atropisomers, deuterated compounds, hydrates, solvates, prodrugs and/or pharmaceutically acceptable salts thereof. The compounds provided by the present invention can effectively degrade and/or inhibit KRAS G12D protein in cells, and can be used for preparing drugs for treating and/or preventing related diseases or disorders caused by KRAS G12D mediation. G-L-E I
Disclaimer: Curated by HT Syndication.
